Roche Holding AG (SWX:ROG)
Switzerland · Delayed Price · Currency is CHF 367.80
-0.40 (-0.11%)
Feb 20, 2026, 5:31 PM CET
Roche Holding AG Employees
Roche Holding AG had 103,249 employees as of December 31, 2024. The number of employees decreased by 356 or -0.34% compared to the previous year.
Employees
103,249
Change (1Y)
-356
Growth (1Y)
-0.34%
Revenue / Employee
613.62K CHF
Profits / Employee
124.75K CHF
Market Cap
293.65B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 103,249 | -356 | -0.34% |
| Dec 31, 2023 | 103,605 | -8 | -0.01% |
| Dec 31, 2022 | 103,613 | 2,693 | 2.67% |
| Dec 31, 2021 | 100,920 | -545 | -0.54% |
| Dec 31, 2020 | 101,465 | 3,730 | 3.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Novartis AG | 75,267 |
| Alcon | 25,000 |
| Sandoz Group AG | 20,000 |
| Lonza Group AG | 19,771 |
| Sonova Holding AG | 18,035 |
| Straumann Holding AG | 11,948 |
| Galenica AG | 7,991 |
| Siegfried Holding AG | 3,926 |
Roche Holding AG News
- 3 hours ago - Roche (RHHBY) Awaits FDA Decision on Giredestrant for Breast Cancer - GuruFocus
- 4 hours ago - Roche granted FDA review for novel breast cancer therapy - Seeking Alpha
- 5 hours ago - FDA Approval For AbbVie/AstraZeneca's Combination Treatment Could Set New Standard For Slow Growing Blood Cancer - Benzinga
- 11 hours ago - FDA Approves Genentech's Venclexta And Acalabrutinib Combo For Untreated CLL - Nasdaq
- 11 hours ago - FDA Approves Genentech's Venclexta® Plus Acalabrutinib Combination Regimen for Previously Untreated Chronic Lymphocytic Leukemia - Business Wire
- 12 hours ago - FDA Accepts New Drug Application for Genentech's Giredestrant in ESR1-Mutated, ER-Positive Advanced Breast Cancer - Business Wire
- 12 hours ago - FDA accepts New Drug Application for Roche's giredestrant in ESR1-mutated, ER-positive advanced breast cancer - GlobeNewsWire
- 3 days ago - Change to the Roche Enlarged Corporate Executive Committee - GlobeNewsWire